FDA approves brexanolone for postpartum depression
Opioids’ pain relief and physical function benefits don’t top NSAIDs in chronic noncancer pain. A barbershop-based hypertension intervention is still going strong a year later. Canakinumab has a remarkable effect on knee and hip replacement risk. And low-tech BMI compares favorably with body scanning for cardiometabolic screening.
We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.